About B-CLE
Upcoming Webcasts
BCLT-Oregon Start-Up Series
Wednesday
|
Session 1: Patent Prosecution and Licensing Basics 1.50 General CLE Credit Available Strong intellectual property can be the backbone of business success—but only if you know how to protect and leverage it. In this practical session, Kathryn Grey, PhD and Alex Yu of Fish & Richardson will walk you through the essentials of patents, ownership, and licensing strategies that every company should master. From understanding the anatomy of a patent to navigating freedom-to-operate issues and structuring licensing agreements, this program offers real-world guidance for innovators, founders, and legal teams alike. Whether you’re growing a startup or managing a mature portfolio, this session will help you align your IP strategy with your business strategy. |
BCLT-Oregon Start-Up Series
Wednesday
|
Session 2: Medical Device IP 101 0.75 General CLE Credit Available Medical device startups face unique IP and regulatory challenges that can define their success. In this engaging session, Tyler Train and Giordana Mahn of Fish & Richardson will guide startups through the essential IP and regulatory strategies that can make or break early success. From securing patent rights to choosing between trade secret protection and public filings, this program will help innovators avoid common pitfalls and lay a strong foundation for growth. |
The Latest and Greatest TCPA Update
Tuesday
|
Location: B-CLE 0.75 General CLE & CPE Credit Available Robocalls, AI-driven outreach, and text message marketing are transforming how businesses communicate—but they also create unprecedented legal risks. The Telephone Consumer Protection Act (TCPA) has become one of the most heavily litigated federal statutes, with class actions and individual lawsuits skyrocketing in recent years. In this engaging session, Eric Troutman “the Czar” from Troutman Amin LLP, one of the nation’s leading TCPA defense attorneys, will break down the latest developments, compliance traps, and defense strategies you need to know to protect your organization. |
BCLT-Oregon Start-Up Series
Wednesday
|
Session 3: Chain of Title General CLE Credit Available A clear chain of title is essential for protecting and leveraging patent rights—but it’s often overlooked. Join us as Priscilla Dodson from Covington for a practical, engaging session that demystifies the concept of “chain of title” in intellectual property law. Through real-world examples and legal insights, this program will explain why tracking patent ownership matters and how to avoid common mistakes that can derail IP enforcement, licensing, or due diligence. Perfect for legal teams, in-house counsel, IP managers, and anyone handling patent assets, this session will give you the tools to secure and verify patent ownership the right way. |
BCLT-Oregon Start-Up Series
Wednesday
|
Session 4: Early-Stage Life Sciences Companies – IP and Trade Secret Strategies 0.75 General CLE Credit Available Launching a life science company comes with big scientific goals—and even bigger IP challenges. Join us in this practical and engaging session, as Goodwin experts Robert Frederickson III and Olivia Uitto, PhD, walk you through how to build and protect your innovation pipeline from day one. Whether you’re navigating patents, trade secrets, or tricky commercialization timelines, this session will help you avoid early missteps and lay the legal groundwork for long-term success. Ideal for founders, legal teams, and early-stage investors, this program offers actionable insight into how to protect your ideas and maximize future value in a complex and competitive industry. |
BCLT-Oregon Start-Up Series
Tuesday
|
Session 5: Understanding Exclusivity Provisions in Technology Consulting Agreements 1.00 General CLE Credit Available Exclusivity provisions can shape the future of business relationships—yet they are often broad, vague, and risky if misunderstood. Join leading legal experts Brent Sokol and Alex Linhardt of Greenberg Traurig for an engaging webcast that unpacks how exclusivity provisions work in technology agreements, what courts have said about their limits, and best practices for drafting, negotiating, and navigating them. Take away actionable strategies and legal insights to better protect your company or clients in a rapidly evolving technology landscape. |
BCLT-Oregon Start-Up Series
Wednesday
|
Session 6: Get Your Ducks In A Row: How Life Science Companies Should Prepare for Intellectual Property Disputes 0.75 General CLE Credit Available In the fast-moving world of life sciences, IP disputes can hit when you least expect them—and the consequences can be costly. Whether you’re asserting your own rights or responding to claims, the best defense is preparation. Join us as Goodwin IP litigation experts Natasha Daughtrey and Josh Weinger, PhD, for a practical guide on how to anticipate and manage intellectual property conflicts from the ground up. Whether you’re scaling a startup or managing a growing portfolio, this session will help you proactively protect your IP and prepare for disputes before they escalate. |
BCLT-Oregon Start-Up Series
Wednesday
|
Session 7: BPCIA & Hatch-Waxman 101 1.25 General CLE Credit Available Join the Berkeley Center for Law & Technology for an engaging session that unpacks two of the most important regulatory frameworks shaping the pharmaceutical and biotech industries: the Hatch-Waxman Act and the Biologics Price Competition and Innovation Act (BPCIA). Our expert presenters, Madelyn McCormick and Dexter Whitley, PhD, will guide participants through the complex—but critical—interplay between patents, exclusivities, and regulatory approvals for small-molecule drugs and biologics. This program offers a practical foundation for understanding how these frameworks balance innovation incentives with market competition, and how they affect litigation, exclusivity rights, and drug pricing. |
BCLT-Oregon Start-Up Series
Tuesday
|
Session 8: M&A Readiness – When Big Pharma Comes Knocking 0.75 General CLE Credit Available Mergers and acquisitions can be pivotal moments for biotech and pharmaceutical companies. When “Big Pharma comes knocking,” boards and executives need to be prepared to respond with clarity, confidence, and a solid understanding of their fiduciary responsibilities. This program, led by Lisa Haddad and Caroline Bullerjahn of Goodwin Procter, will guide participants through the key considerations, duties, and processes that ensure organizations are ready when opportunities—or challenges—arise. |
Tech Tuesday Weekly Offerings
Welcome to Tech Tuesdays, our weekly offerings of select B-CLE on-demand courses.
Enrollment and CLE are complimentary with the code: BCLT-TechTues. Apply the code during check-out (case and character sensitive). This code is only good for the program(s) listed below. A B-CLE account is required to enroll in B-CLE courses. Subscribe at no charge.
US-UK On Fair Use
0.75 General CLE Credit Available |
Location: B-CLE Generative AI is transforming creative industries—and igniting legal battles across the globe. As U.S. and U.K. high profile cases are testing the limits of fair use, courts are being asked to define how copyright, trademarks, and data rights apply in the age of machine learning. Join Rajvinder Jagdev (Powell Gilbert, London) and Dr. Chris Mammen (Womble Bond Dickinson, San Francisco) for a lively, cross-Atlantic conversation on the latest litigation, legislative developments, and what creators, tech companies, and lawyers need to know now. |
California’s Cybersecurity Audit Rule
0.75 General CLE Credit Available |
Location: B-CLE With compliance deadlines starting in 2028 and strict requirements for risk assessments, data governance, and audit procedures, new cybersecurity rules are on the horizon. Join us in this timely and practical session as renowned privacy and cybersecurity expert Jim Dempsey breaks down California’s groundbreaking new CPRA cybersecurity audit rule, what it means for your organization, and how to prepare now to avoid legal and regulatory pitfalls later. Whether you’re a privacy officer, general counsel, CISO, or advising California-facing clients, this is a can’t-miss session on the future of data security regulation. |
3rd BCLT Advanced Life Sciences Institute Series
2.00 General CLE Credit Available |
2-Part Series + Royalty Finance, the UCC and Issues of Recharacterization Subseries Life sciences technologies continue to develop and evolve, regulatory agencies undergo rapid change, and the practice of life sciences law moves at an ever-increasing pace. To make sure you are up to date, the 3rd BCLT Advanced Life Sciences Institute series is mandatory viewing on key cutting-edge issues impacting your practice. |
Royalty Finance, the UCC and Issues of Recharacterization
2.75 Total General CLE Credit Available |
3-Part Series Revisit our three-part exploration of royalty financing for life sciences companies to hear updates on: 1) the application of safe harbor provisions and FDA laboratory test regulation and, 2) key developments in the law related to patent disclosure. In this three-part virtual series, BCLT & Gibson, Dunn & Crutcher have partnered issues originally raised in a Law 360 article written by Gibson Dunn attorneys, Todd Trattner and Ryan Murr, entitled How Biotech Cos. Can Utilize Synthetic Royalty Financing. Gibson Dunn attorneys explored, in depth, royalty finance, looking at synthetic royalties, the treatment of synthetics under the UCC, and the risks of a sale of a synthetic royalty being recharacterized as a loan in bankruptcy. The aim of this virtual speaker series is to educate biotechnology stake holders (investors, entrepreneurs, companies, and their attorneys) on best practices for monetizing and investing in a synthetic royalty so that they may embark on such transactions with greater certainty. For anyone with an interest in how modern biotechnology companies raise capital, this series will help you optimize your rights and reduce your risks. Don’t miss it! |
2025 BCLT Privacy Law Forum: Life Sciences
0.75 General CLE & CPE Credit Available |
Session 1: International Data Transfers Watch a panel with Lokke Moerel and Kaylee Cox Bankston from Morrison Foerster to learn what you need to know about international data transfers. Lokke and Kaylee explored the US and EU international data transfer regimes in detail, and how lawyers and clients can best navigate these complex regimes in these changing geo-policital times. The EU data transfer regime has started out as a protection of fundamental privacy rights of individuals but is now becoming a tool in the EU’s ambition for digital sovereignty. Lokke discussed why the EU’s digital sovereignty is under threat, what the chances are the EU-US Data Privacy Framework will be invalidated, how EU policy measures facilitated open data spaces for AI innovation while ensuring EU sovereignty by introducing further transfer regimes (basically amounting to data localization requirements) and how Big Tech responded with EU cloud boundaries. The session ended with recommendations for how to navigate this complex legal landscape. Don’t miss this excellent program! |